Archive

AIRIS 2024 Overview AIRIS 2024 Program AIRIS 2024 Gallery
/

Archive

/

AIRIS 2024 Program

AIRIS 2024 Program

Opening Ceremony DYNASTY Hall 1, 2
Plenary Address DYNASTY Hall 1, 2
Session Topic
Topic
Speaker
File
Keynote Speech 1
Innovating Healthcare for the Future: The Role and Prospects of AI
In Chul Hwang

Corporate Executive Vice President (Head of AI RnD), Samsung Electronics

Keynote Speech 2
GenAI Revelations from the Video Games Industry - Unleashed on Life Sciences
Sam Glassenberg

Founder & CEO, Level Ex

Session 1: Introduction to AI - Use of AI in Medical Product Development DYNASTY Hall 1, 2
Session Topic
Topic
Speaker
File
Presentation 1
The Hinge Moment: Artificial Intelligence, Human Data, and Drug Development in the 21st Century
David Reese

MD, Executive Vice President, Amgen

Presentation 2
The Potential of AI in Biopharmaceutical Development
Chaok Seok

Professor/CEO, Seoul National University/Galux

Presentation 3
AI / ML - Enabled Medical Devices: Further Challenges that Generative AI Poses
Johan Ordish

Head of Digital Health and Innovation Policy, Roche

Presentation 4
Open innovation for Medical AI development - Introduction of Dr. Answer 2.0 project -
Ho-Young Lee

Professor, Seoul National University Bundang Hospital

Dinner (For speakers and regulatory authorities) C
Session 2 : Transparency, Explainability, and Bias DYNASTY Hall 1, 2
Session Topic
Topic
Speaker
File
Presentation 1
Explainability & safe use of LLMs in clinical development
Stephen Pyke

Chief Clinical Data & Digital Officer, Parexel

Presentation 2
Principles and Applications of Explainable Artificial Intelligence
Jaesik Choi

Professor, KAIST

Presentation 3
Behavioral and Human Factors Considerations for Effective and Trustworthy Health AI
Merage Ghane

Ph.D Principal Behavioral Designer, Ideas42

Presentation 4
Algorithmic Bias, Old and New
Arjun Manrai

PhD, Assistant Professor of Biomedical Informatics, Harvard Medical School

Presentation 5
Gap Exposed by AI: Bias from Legal Perspective and from Medical Perspective
Won Bok Lee

Professor, Ehwa Law School

Presentation 6
Tools for transparency: from data to development to device(this can be modified)
Alastair Denniston

Hon Professor, University of Birmingham

Presentation 7
Transparency of AI from User's Perspective
Seong Ho Park

Professor, University of Ulsan College of Medicine

Luncheon (For speakers and regulatory authorities) C
Session 3 : AI Technology Trends for Medical Product Development DYNASTY Hall 1, 2
Session Topic
Topic
Speaker
File
Presentation 1
Trends and Convergence (including Standards) - Lessons Learned from other fields
Pat Baird

Regulatory Head of Global Software Standards, Phillips

Presentation 2
Quality assurance and improvement for Machine Learning-based clinical decision support systems
Jean Feng

Assistant Professor, Epidemiology & Biostatistics, UCSF

Presentation 3
Technical Standardization Trends on AI/ML-MD Performance Evaluation
Jonghong Jeon

Principal Researcher, Electronics and Telecommunications Research Institute

Presentation 4
The current and emerging use of AI in safety surveillance post-marketing
Andrew Bate

VP Safety Innovation and Analytics, GSK

Presentation 5
Leveraging network analysis and graph deep learning for drug discovery
Sun Kim

Professor, Seoul National University

Dinner (For speakers and regulatory authorities) C
Session 4 : Regulatory Experience on the Use of AI in Medical Products DYNASTY Hall 1, 2
Session Topic
Topic
Speaker
File
Presentation 1
Lunit＇s Global Regulatory Experience and Insights.
Sunggyun Park

Chief Product Officer, Lunit

Presentation 2
Predetermined Change Control Plans Supporting Efficient Regulatory Oversight of AI-Enabled Products
Cassie Scherer

Senior Director of U.S. Regulatory and Global Digital Health Policy, Medtronic

Presentation 3
Industry Perspectives on Regulatory Frameworks for AI/ML in Drug Development
Ryan Hoshi

Director, Regulatory Policy & Intelligence, AbbVie

Presentation 4
Standardized patient profile review using large language models for case adjudication in observational research
Martijn Schuemie

Research Fellow, Johnson & Johnson/OHDSI

Luncheon (For speakers and regulatory authorities) C
Session 5 : New Medical Products and Treatment Opportunities Using AI DYNASTY Hall 1, 2
Session Topic
Topic
Speaker
File
Presentation 1
Unlocking rapid and safe innovation using Federated Computing
Ittai Dayan

MD, MPH, Co-founder and CEO, Rhino Health

Presentation 2
Precision Medicine at Scale: towards finding the right treatment for every patient
Joseph Lehar

PhD, Innovator · Executive · Advisor, SVP>SAB at Owkin

Presentation 3
AI-based Clinical Decision Support System (CDSS) and its Clinical Validation
Hwiyoung Kim

Professor, Yonsei University College of Medicine

Presentation 4
Current Landscape of Generative AI and Its Applications in Medicine
Kyu Hwan Jung

Professor, Sungkyunkwan University

Presentation 5
Causal AI for Learning “Digital Twins” from Human Multi-OmicData for Drug Discovery and Clinical Development: A Cardiovascular Disease Case Study
Bruce Church

Chief Mathematics Officer, Aitia

Dinner (For speakers and regulatory authorities) C
Session 6 : Regulatory Considerations and International Cooperation Plans for Using AI in Medical Product Development Yeong Bin Gwan TOPAZ
Luncheon (For speakers and regulatory authorities) C
Session 7 : Outcome and Summary of AIRIS Yeong Bin Gwan TOPAZ
Closing Ceremony Yeong Bin Gwan TOPAZ
* CClosed Event